UBS Group
CORZ icon

UBS Group’s Core Scientific CORZ Stock Holding History

UBS Group’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407M Sell
15,889,496
-9,644,444
-38% -$227M 0.05% 372
2026
Q1 		$382M Buy
25,533,940
+5,716,683
+29% +$97.5M 0.06% 341
2025
Q4 		$289M Buy
19,817,257
+13,232,490
+201% +$231M 0.05% 399
2025
Q3 		$118M Buy
6,584,767
+2,238,491
+52% +$32.8M 0.02% 916
2025
Q2 		$74.2M Buy
4,346,276
+260,434
+6% +$2.61M 0.01% 1189
2025
Q1 		$29.6M Sell
4,085,842
-1,168,676
-22% -$13.3M 0.01% 1965
2024
Q4 		$73.8M Buy
5,254,518
+4,141,435
+372% +$61.2M 0.01% 1132
2024
Q3 		$13.2M Buy
1,113,083
+388,321
+54% +$4.02M ﹤0.01% 2140
2024
Q2 		$6.74M Buy
724,762
+723,621
+63,420% +$3.7M ﹤0.01% 2567
2024
Q1 		$4.04K Buy
+1,141
New +$3.96K ﹤0.01% 7667

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group's CORZ Position: Q2 2026 in Review

UBS Group reduced its Core Scientific (CORZ) stake by 38% in Q2 2026, selling an estimated $227M and leaving 15,889,496 shares worth $407M. The position accounts for 0.05% of the portfolio, ranked #372.

UBS Group first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • UBS Group held 15,889,496 shares of Core Scientific worth $407M as of Q2 2026.
  • UBS Group sold 9,644,444 Core Scientific shares in Q2 2026, an estimated $227M.
  • Core Scientific made up 0.05% of UBS Group's portfolio in Q2 2026, its #372 holding.
  • UBS Group first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.